Dexmedetomidine improved renal function in patients with severe sepsis: an exploratory analysis of a randomized controlled trial

BACKGROUND: Dexmedetomidine has been reported to improve organ dysfunction in critically ill patients. In a recent randomized controlled trial (Dexmedetomidine for Sepsis in Intensive Care Unit (ICU) Randomized Evolution [DESIRE]), we demonstrated that dexmedetomidine was associated with reduced mor...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakashima, Tsuyoshi, Miyamoto, Kyohei, Shima, Nozomu, Kato, Seiya, Kawazoe, Yu, Ohta, Yoshinori, Morimoto, Takeshi, Yamamura, Hitoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939335/
https://www.ncbi.nlm.nih.gov/pubmed/31908779
http://dx.doi.org/10.1186/s40560-019-0415-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939335/
https://www.ncbi.nlm.nih.gov/pubmed/31908779
http://dx.doi.org/10.1186/s40560-019-0415-z

Ejemplares similares